Orion Group Interim Report JanuaryMarch 2025
ORION CORPORATION INTERIM REPORT 1–3/2025 23 APRIL 2025 at 12:00 EEST Orion…
Pharming receives positive recommendation from NICE for Joenja(leniolisib) as a treatment for APDS
For media and investors only Joenja® is the first and only medicine…
Boehringer Ingelheim and Tessellate Bio partner to develop first-in-class precision treatments for people with hard-to-treat cancers
Ingelheim, Germany and Amsterdam, the Netherlands, 23 April 2025 – Boehringer Ingelheim…
Cytovation Raises US$6m to Advance Phase 2 Development of CY-101 in Adrenocortical Carcinoma to First Clinical Readouts
April 23, 2025 03:00 ET | Source: Cytovation New funds provided largely…
Antag Therapeutics expands senior team to support clinical progress
Copenhagen, Denmark, 23 April 2025 – Antag Therapeutics (“Antag” or “the Company”),…
SCIENTURE announces manufacturing and supply chain readiness for ArbliTM, (losartan potassium) Oral Suspension, 10mg/mL for a target product launch in July 2025.
TAMPA, FL, April 22, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. NASDAQ:…
Catalyst Pharmaceuticals to Report First Quarter 2025 Financial Results on May 7, 2025
CORAL GABLES, Fla., April 22, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst"…
FluidForm Bio Strengthens IP Portfolio with Newly Issued Patent on Key Aspects of its Proprietary FRESH Platform
April 22, 2025 08:00 ET | Source: FluidForm Bio WALTHAM, Mass., April…
Ocean Biomedical Expands into Energy and Digital Asset Sectors to Accelerate Growth and Shareholder Value
Strategic diversification into power infrastructure and cryptocurrencies supports long-term biopharma innovation PROVIDENCE,…